BCS

OTHER2 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, SURGE Therapeutics

Conditions

Alzheimer's Disease (AD)Frontotemporal Degeneration (FTD)Lewy Body Dementia (LBD)TNBC - Triple-Negative Breast Cancer

Phase 3

Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing Breast-Conserving Surgery

Not yet recruitingNCT07723469

SURGE TherapeuticsTNBC - Triple-Negative Breast Cancer

Start: 2026-10-01End: 2034-10-01Target: 400Updated: 2026-07-23

Unknown Phase

Social-cognitive Functioning: Validation of a New Neuropsychological Test

RecruitingNCT05558709

Assistance Publique - Hôpitaux de ParisAlzheimer's Disease (AD), Frontotemporal Degeneration (FTD), Lewy Body Dementia (LBD)

Start: 2026-02-04End: 2030-02-04Target: 120Updated: 2026-03-13